Why the study?
Are there sex disparities in the treatment and control of cardiovascular risk factors between women and men with type 2 diabetes and CVD?
Are there sex disparities in the treatment and control of cardiovascular risk factors between women and men with type 2 diabetes and CVD?
This study highlights significant sex disparities in secondary prevention for patients with type 2 diabetes, with women receiving less intensive lipid-lowering therapy and achieving poorer risk factor control.
No takes yet. Share an insight, caveat, or question.
May signal need for clinician vigilance on sex disparities in secondary prevention; leaves open whether targeted strategies improve outcomes in women.
Gouni‐Berthold et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: